Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI?: Commentary.
作者信息
Siew Edward D
机构信息
Division of Nephrology and Hypertension, Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury (AKI), Vanderbilt University Medical Center, Nashville, Tennessee and Tennessee Valley Health Systems (TVHS), Nashville Veterans Affairs Hospital, Tennessee.
出版信息
Kidney360. 2023 Dec 1;4(12):1670-1671. doi: 10.34067/KID.0000000000000240.
Abstract
摘要
相似文献
1
Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI?: Commentary.
Kidney360. 2023 Dec 1;4(12):1670-1671. doi: 10.34067/KID.0000000000000240.
2
The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review.
Inflamm Allergy Drug Targets. 2011 Aug;10(4):260-71. doi: 10.2174/187152811796117735.
3
Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.
Am J Kidney Dis. 2015 Dec;66(6):993-1005. doi: 10.1053/j.ajkd.2015.06.018. Epub 2015 Aug 5.
4
Differences in acute kidney injury ascertainment for clinical and preclinical studies.
Nephrol Dial Transplant. 2017 Nov 1;32(11):1789-1805. doi: 10.1093/ndt/gfx002.
5
Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.
Kidney Int. 2008 May;73(9):1008-16. doi: 10.1038/sj.ki.5002729. Epub 2007 Dec 19.
6
Soluble average Klotho level as a prognostic marker for acute kidney injury outcomes: a 90-day follow-up study.
Biomark Med. 2025 Apr;19(7):243-250. doi: 10.1080/17520363.2025.2481018. Epub 2025 Mar 22.
7
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis.
J Hepatol. 2024 Jan;80(1):62-72. doi: 10.1016/j.jhep.2023.10.010. Epub 2023 Oct 20.
8
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences.
Clin Chem Lab Med. 2012 Feb 15;50(9):1505-17. doi: 10.1515/cclm-2011-0814.
9
Time Course of Kidney Injury Biomarkers in Children With Septic Shock: Nested Cohort Study Within the Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis Trial.
Pediatr Crit Care Med. 2025 Jun 1;26(6):e816-e826. doi: 10.1097/PCC.0000000000003737. Epub 2025 Apr 2.
10
The definition of acute kidney injury and its use in practice.
Kidney Int. 2015 Jan;87(1):62-73. doi: 10.1038/ki.2014.328. Epub 2014 Oct 15.
本文引用的文献
1
Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness.
Clin J Am Soc Nephrol. 2023 Aug 1;18(8):997-1005. doi: 10.2215/CJN.0000000000000203. Epub 2023 May 31.
2
Assessment of kidney proximal tubular secretion in critical illness.
JCI Insight. 2021 May 24;6(10):145514. doi: 10.1172/jci.insight.145514.
3
Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial.
Anesth Analg. 2021 Aug 1;133(2):292-302. doi: 10.1213/ANE.0000000000005458.
4
Rationale and design of the Kidney Precision Medicine Project.
Kidney Int. 2021 Mar;99(3):498-510. doi: 10.1016/j.kint.2020.08.039.
5
A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children.
Kidney Int. 2020 Mar;97(3):580-588. doi: 10.1016/j.kint.2019.10.015. Epub 2019 Nov 1.
6
Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.
JCI Insight. 2019 May 16;4(10). doi: 10.1172/jci.insight.127456.
7
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.
8
Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy.
Am J Respir Crit Care Med. 2019 Apr 1;199(7):863-872. doi: 10.1164/rccm.201807-1346OC.
9
Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
Am J Kidney Dis. 2017 Dec;70(6):807-816. doi: 10.1053/j.ajkd.2017.06.031. Epub 2017 Aug 24.
10
Imperfect gold standards for kidney injury biomarker evaluation.
J Am Soc Nephrol. 2012 Jan;23(1):13-21. doi: 10.1681/ASN.2010111124. Epub 2011 Oct 21.
Zotero 插件